Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Ramming

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
Nature|February 1, 2019
PU.1 controls fibroblast polarization and tissue fibrosisThomas Wohlfahrt, Simon Rauber, Steffen Uebe, et al.
The Lancet. Rheumatology|November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases frameworkEmanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
Nature Immunology|February 24, 2024
CD200<sup>+</sup> fibroblasts form a pro-resolving mesenchymal network in arthritisSimon Rauber, Hashem Mohammadian, Christian Schmidkonz, et al.
Nature Immunology|January 2, 2026
Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to jointsMaria G Raimondo, Hashem Mohammadian, Mario R Angeli, et al.
European Journal of Immunology|October 6, 2023
Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infectionAnis Barmada, Louis-François Handfield, Gerard Godoy-Tena, et al.
Nature Communications|February 28, 2025
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targetsNick Dand, Philip E Stuart, John Bowes, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targetsNick Dand, Philip E Stuart, John Bowes, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Nature Communications|May 23, 2026
Deep phenotyping of skin tissue remodeling in patients with systemic sclerosis treated with CD19-CAR T cellsAleix Rius Rigau, Meilin Xu, Ziyuan Liu, et al.
Nature|February 1, 2019
PU.1 controls fibroblast polarization and tissue fibrosisThomas Wohlfahrt, Simon Rauber, Steffen Uebe, et al.
The Lancet. Rheumatology|November 1, 2024
Identification of red flags for IgG4-related disease: an international European Reference Network for Rare Connective Tissue Diseases frameworkEmanuel Della-Torre, Rosaria Talarico, Jose Ballarin, et al.
Nature Immunology|February 24, 2024
CD200<sup>+</sup> fibroblasts form a pro-resolving mesenchymal network in arthritisSimon Rauber, Hashem Mohammadian, Christian Schmidkonz, et al.
Nature Immunology|January 2, 2026
Skin-derived myeloid precursors and joint-resident fibroblasts spread psoriatic disease from skin to jointsMaria G Raimondo, Hashem Mohammadian, Mario R Angeli, et al.
European Journal of Immunology|October 6, 2023
Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infectionAnis Barmada, Louis-François Handfield, Gerard Godoy-Tena, et al.
Nature Communications|February 28, 2025
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targetsNick Dand, Philip E Stuart, John Bowes, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
GWAS meta-analysis of psoriasis identifies new susceptibility alleles impacting disease mechanisms and therapeutic targetsNick Dand, Philip E Stuart, John Bowes, et al.
Pageof 10